Clinical correlation between increased lung to heart ratio of technetium-99m sestamibi and multivessel coronary artery disease

Int J Cardiol. 2005 May 25;101(2):219-22. doi: 10.1016/j.ijcard.2004.03.020.

Abstract

Background: An increased lung to heart ratio (LHR) on thallium-201 (Tl-201) stress myocardial perfusion imaging (MPI) is a predictor of adverse cardiac events and identifies people with extensive coronary artery disease (CAD). The implications of increased LHR in patients undergoing stress technetium-99m (tc-99m) sestamibi are developing. Our aim is to evaluate the relationship between increased LHR and extent of CAD in patients undergoing tc-99m sestamibi MPI.

Methods: We reviewed the records and images of 530 consecutive subjects who underwent exercise or adenosine tc-99 m sestamibi MPI. One hundred thirty-two had transient or partially reversible myocardial perfusion defects and 79 (exercise=34, adenosine=45, male=43, female=36, mean age=61 years) of these underwent coronary angiography (study population). The average LHR of these 79 subjects was compared to 79 patients (control population) with normal scans (exercise=50, adenosine=29, male=34, female=45, mean age=60 years).

Results: The mean LHR (+/-SE) in subjects with normal scans was 0.30+/-0.01. The mean LHR for those with abnormal scans and single vessel CAD who underwent exercise was 0.32+/-0.01 and pharmacological stress was 0.31+/-0.01. There was no statistically significant difference between the LHR of those with a normal scan and those with single vessel disease and an abnormal scan. However, there was a statistically significant association between the elevated LHR and multi-vessel CAD. The mean LHR for subjects with multi-vessel CAD with exercise was 0.39+/-0.01 (p=0.000) and for adenosine was 0.39+/-0.02 (p=0.000).

Conclusion: An elevated LHR in patients undergoing exercise or pharmacological tc-99m MPI correlates with multi-vessel CAD.

MeSH terms

  • Adenosine
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / metabolism*
  • Coronary Artery Disease / physiopathology
  • Coronary Circulation / physiology
  • Exercise Test
  • Female
  • Humans
  • Lung / metabolism*
  • Male
  • Middle Aged
  • Myocardium / metabolism*
  • Radionuclide Imaging
  • Radiopharmaceuticals / pharmacokinetics*
  • Retrospective Studies
  • Severity of Illness Index
  • Technetium Tc 99m Sestamibi / pharmacokinetics*
  • Vasodilator Agents

Substances

  • Radiopharmaceuticals
  • Vasodilator Agents
  • Technetium Tc 99m Sestamibi
  • Adenosine